IDEXX LABORATORIES INC /DE Quarterly Goodwill in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Idexx Laboratories Inc /De quarterly Goodwill history and growth rate from Q2 2010 to Q3 2024.
  • Idexx Laboratories Inc /De Goodwill for the quarter ending September 30, 2024 was $412M, a 13.9% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $412M +$50.3M +13.9% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $408M +$43.8M +12% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $409M +$45.7M +12.6% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $366M +$4.17M +1.15% Dec 31, 2023 10-Q 2024-10-31
Q3 2023 $362M +$6.47M +1.82% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $364M +$8.68M +2.44% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $363M +$1.97M +0.55% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $362M +$2.45M +0.68% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $355M +$52K +0.02% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $356M +$1.69M +0.48% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $361M +$118M +48.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $359M +$116M +47.7% Dec 31, 2021 10-K 2024-02-22
Q3 2021 $355M +$117M +49.2% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $354M +$118M +50.3% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $243M +$9.38M +4.02% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $243M +$3.62M +1.51% Dec 31, 2020 10-K 2024-02-22
Q3 2020 $238M +$25.9M +12.2% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $235M +$20.3M +9.42% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $233M +$18.7M +8.71% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $240M +$25.2M +11.8% Dec 31, 2019 10-K 2023-02-16
Q3 2019 $212M -$3.88M -1.79% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $215M +$19.2M +9.79% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $215M +$13.5M +6.71% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $214M +$14.6M +7.31% Dec 31, 2018 10-K 2022-02-16
Q3 2018 $216M +$16.5M +8.28% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $196M -$696K -0.35% Jun 30, 2018 10-Q 2018-08-01
Q1 2018 $201M +$20.4M +11.3% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $200M +$21.6M +12.1% Dec 31, 2017 10-K 2021-02-12
Q3 2017 $200M +$18.6M +10.3% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $197M +$16M +8.86% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 $181M -$1.34M -0.74% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $178M -$706K -0.4% Dec 31, 2016 10-K 2020-02-14
Q3 2016 $181M +$560K +0.31% Sep 30, 2016 10-Q 2016-11-01
Q2 2016 $181M +$952K +0.53% Jun 30, 2016 10-Q 2016-08-02
Q1 2016 $182M +$5.01M +2.83% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $179M -$5.52M -2.99% Dec 31, 2015 10-K 2019-02-15
Q3 2015 $180M +$3.86M +2.18% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $180M -$1.91M -1.05% Jun 30, 2015 10-Q 2015-07-30
Q1 2015 $177M -$3.53M -1.96% Mar 31, 2015 10-Q 2015-04-28
Q4 2014 $184M +$3.93M +2.18% Dec 31, 2014 10-K 2018-02-16
Q3 2014 $177M -$4.45M -2.46% Sep 30, 2014 10-Q 2014-10-24
Q2 2014 $182M +$10.2M +5.96% Jun 30, 2014 10-Q 2014-07-25
Q1 2014 $180M +$8.01M +4.64% Mar 31, 2014 10-Q 2014-04-25
Q4 2013 $181M +$5.53M +3.16% Dec 31, 2013 10-K 2017-02-17
Q3 2013 $181M +$6.37M +3.65% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $171M +$474K +0.28% Jun 30, 2013 10-Q 2013-07-23
Q1 2013 $172M -$2.65M -1.51% Mar 31, 2013 10-Q 2013-04-23
Q4 2012 $175M +$2.38M +1.38% Dec 31, 2012 10-K 2016-02-17
Q3 2012 $175M +$24.6M +16.4% Sep 30, 2012 10-Q 2012-10-19
Q2 2012 $171M +$16.7M +10.9% Jun 30, 2012 10-Q 2012-07-20
Q1 2012 $175M +$22.6M +14.8% Mar 31, 2012 10-Q 2012-04-20
Q4 2011 $173M +$23.5M +15.8% Dec 31, 2011 10-K 2015-02-17
Q3 2011 $150M +$1.42M +0.96% Sep 30, 2011 10-Q 2011-10-21
Q2 2011 $154M +$10.9M +7.64% Jun 30, 2011 10-Q 2011-07-22
Q1 2011 $152M Mar 31, 2011 10-Q 2011-04-21
Q4 2010 $149M Dec 31, 2010 10-K 2014-02-18
Q3 2010 $149M Sep 30, 2010 10-Q 2010-10-22
Q2 2010 $143M Jun 30, 2010 10-Q 2010-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.